MSEX exhibits a stable but stagnant financial profile with a Piotroski F-Score of 5/9, yet it is fundamentally overvalued. The current price of $51.86 trades at a significant premium to both the Graham Number ($37.63) and the growth-based Intrinsic Value ($16.52). Negative revenue and earnings growth, coupled with a consistent track record of missing quarterly estimates (0/4 in the last year), suggest a lack of operational momentum. Severe liquidity constraints, evidenced by a current ratio of 0.45, further heighten the risk profile.